Last week, the CONQUEST team had the incredible opportunity to visit Japan! 🇯🇵
CONQUEST is a global platform clinical trial created by the Scleroderma Research Foundation with input from partner biopharmaceutical companies to accelerate the development of possible new treatments for scleroderma.
In Tokyo, the CONQUEST team met with dedicated physicians who are part of this international effort, providing training on how the study works and answering their questions.
By creating a global network of scleroderma treatment centers, CONQUEST aims to make a widespread impact, and it is currently enrolling patients! We encourage individuals who have SSc-ILD to consider participation in CONQUEST.
